Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial

Autor: Claire Rouzaud, Véronique Joly, Babacar Sylla, Jacques Leibowitch, Lio Collias, Noemie Biezunski, Dominique Costagliola, Damien Le Dû, Jacques Izopet, Irène Zamord, Jonathan Bellet, Sandrine Gohier, Julie Chas, Dominique Bornarel, Sylvie Dargere, Karine Amat, Olivier Bouchaud, Jean-Claude Melchior, David Zucman, Martin Duracinsky, Huguette Berthe, Roland Landman, Adrien Lemaignen, Soizic Le Mestre, Lionel Piroth, Arnaud de la Blanchardiere, Amélie Chabrol, Emuri Abe, Pierre Delobel, Dominique Mathez, Frédéric Fourreau, Juliette Saillard, Louis Bernard, Laurence Weiss, Jean-François Delfraissy, Stéphanie Landowski, Jean-Claude Alvarez, André Cabié, Pierre-Marie Girard, Lambert Assoumou, Luminita Schneider, Jean-Luc Meynard, Jacques Reynes, Karine Lacombe, Alain Devidas, Mathilde Pircher, Fatima Touam, Séverine Gibowski, Pierre de Truchis, Guillaume Gras, Aida Benalicherif, Christian Perronne, Vincent Le Moing, Christine Katlama, Pélagie Thibault, Cécile Goujard, Bao Phung

Publikováno v: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2018, 73 (3), pp.738-747. 〈10.1093/jac/dkx434〉
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2018, 73 (3), pp.738-747. ⟨10.1093/jac/dkx434⟩

International audience; Background:Intermittent treatment could improve the convenience, tolerability and cost of ART, as well as patients' quality of life. We conducted a 48 week multicentre study of a 4-days-a-week antiretroviral regimen in adults

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c4b555c272b0090d5b41940885c8d72
https://hal.archives-ouvertes.fr/hal-01740290